Open AccessINTRAVITREAL RANIBIZUMAB TREATMENT FOR ADVANCED FAMILIAL EXUDATIVE VITREORETINOPATHY WITH HIGH VASCULAR ACTIVITY
Author(s) -
Jungmook Lyu,
Qi Zhang,
Yu Xu,
Xiang Zhang,
Ping Fei,
Peiquan Zhao
Publication year - 2021
Publication title -
retina
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.24
H-Index - 120
eISSN - 1539-2864
pISSN - 0275-004X
DOI - 10.1097/iae.0000000000003122
Subject(s) - proliferative vitreoretinopathy , medicine , ranibizumab , vitrectomy , ophthalmology , retinopathy , retinal , fundus (uterus) , quadrant (abdomen) , surgery , visual acuity , chemotherapy , diabetes mellitus , bevacizumab , endocrinology
To determine the efficacy of intravitreal ranibizumab (IVR) treatment for advanced familial exudative vitreoretinopathy with high vascular activity.